Biocon Ltd Board Meeting on Aug 5 to Approve Q1 FY27 Results

Biocon Ltd has announced a Board of Directors meeting scheduled for August 5, 2026, to approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Concurrently, the company has closed its trading window from July 1, 2026, to August 7, 2026, reopening on August 8, 2026, in line with insider trading regulations. An earnings conference call for analysts and investors is scheduled for August 6, 2026, to discuss the financial performance. The company will provide recordings and transcripts of the call on its website.